Dexamethasone, an inexpensive steroid, reduced death by one-third in ventilated COVID-19 patients, and by one fifth in patients receiving oxygen for severe coronavirus symptoms. Preliminary findings suggest one death per eight patients ventilated could be prevented by administering dexamethasone.